Navigation Links
Abbott Offers Aluvia to Thailand in Return for Compulsory Licensing Halt

Abbott Laboratories said this week that it is willing to proceed with the registration of a heat stable version of lopinavir/ritonavir called Aluvia in Thailand if the Thai// government will halt its plans for a compulsory license to allow imports of a generic version from India, and will sell it to the Thai government for $1000 a year.

Abbott has been in dispute with the Thai government since January 2007, when plans for a compulsory license to import lopinavir/ritonavir were first announced by the Thais. Abbott retaliated by withdrawing seven products from drug registration processes in Thailand, including Aluvia.

In February Abbott offered a price cut to $167 a month for Kaletra, the soft-gel capsule version of lopinavir/ritonavir.

Earlier in April Abbott announced that it was cutting the price of Kaletra and Aluvia when registered to $1000 a year in 40 lower middle-income countries following discussions with World Health Organization director-general Margaret Chan. But the company said that its offer would only apply where its patents are respected, a clear warning to the Thai government.

According to the Wall Street Journal, Abbott chief executive Miles White said that the decision to withdraw Aluvia from registration had been driven by “concern that compulsory licensing would be abused ever-more widely, using HIV as an excuse."

But last month Abbott public affairs staff insisted that the company’s action was not related to HIV drugs, but to a lack of respect for `numerous` patents.

Treatment advocates have urged the Thai government not to back down on its compulsory licensing policy.

“The fact that Thailand has been brave enough to issue a compulsory license means that 40 countries are now able to get Kaletra for $1000 a year,” said Paul Cawthorne, head of mission for Médecins sans Frontières in Thailand, speaking during a phone briefing for journalists earlier today.
The Thai government says that negotiations will continue.

A version of lopinavir/ritonavir alleged to be heat-stable was recently launched by the Indian company Emcure. However no data is available on the manufacturer’s website to explain the stablility of Emletra, and the product has not been prequalified by the World Health Organization.

Source-Generef.com'"/>




Related medicine news :

1. Pharmacia may take 51.5 percent Abbott stake
2. Abbott Laboratories to buy Biocompatibles cardiovascular stent business
3. Abbott’s Laboratories R&D Capabilities Questione
4. Abbott Receives CE Mark Certification
5. Abbott to Subsidize Price of HIV Drug
6. Pancreatitis: Minimially Invasive Procedure Offers Long-Term Pain Relief
7. Drug Offers Hope for Alzheimers disease
8. Drug Firm Offers to Donate Smallpox Vaccine
9. fMRI Offers Insight Into An Infants Brain
10. Gel Offers A More Targeted Approach
11. Umbilical Cord Blood Offers Hope For Patients Who Require Bone Marrow Transplants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... , ... The pandemic and topsy-turvy economic outlook continues to put financial strain on many of ... trim the fat from our monthly expenses and put more into savings, if possible. , ... have a financial safety net in place in case something were to happen to you,” ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... improve outcomes for patients with advanced heart failure, today announced that the company ... the amount of $555,358 from the National Heart, Lung, and Blood Institute of ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... to a customized Lighthouse Health & Wellness mobile app and web-portal. NCPCV received ... Motorola Solutions Foundation awards grants each year to organizations, such as Destination Imagination, ...
(Date:8/28/2020)... ... 2020 , ... A July 27 article on ... an increased risk of developing severe COVID-19 symptoms. The article does not suggest ... same organ systems that the coronavirus attacks are already suffering from the adverse ...
(Date:8/26/2020)... ... August 26, 2020 , ... Smile Brands Inc. CEO, ... Online Forum, leading a session entitled, “A CEO Guide for Delivering and Measuring ... designed to bring together the world’s leading diversity and inclusion executives, HR consultants, ...
Breaking Medicine News(10 mins):
(Date:8/26/2020)... DIEGO (PRWEB) , ... August 26, 2020 , ... AseptiScope, ... 2020 Infection Control Company of the Year by MedTech Outlook. , “AseptiScope ... Officer. “For the first time, clinicians who wear gloves on their hands, goggles on ...
(Date:8/26/2020)... ... ... As the U.S. struggles in its 6th month of fighting Covid-19, Americans are ... keep your distance, wash your hands. Prevention is the best tool for now. Noted ... much better it is to prevent disease than to cure it.” , Part of ...
(Date:8/26/2020)... ... August 26, 2020 , ... NucleusHealth, LLC, a provider of ... President and Chief Executive Officer effective immediately. Dr. Vishal Verma, the previous CEO, ... Managers. , Mr. Hooton, a seasoned business executive, joined the company in ...
Breaking Medicine Technology: